Microbial lipids

Microbial lipids are a heterogeneous and essential group of molecules that constitute the structural framework of cell membranes and cell walls in bacteria, fungi, and other microorganisms [1, 8]. This broad category encompasses specific targets such as Lipid A (the endotoxic component of the Gram-negative bacterial lipopolysaccharide), Lipid II (a key precursor in peptidoglycan biosynthesis), and ergosterol (the primary sterol in fungal cell membranes) [3, 8, 15]. These lipids are crucial for maintaining structural integrity, regulating membrane permeability, and facilitating the spatial organization of membrane proteins necessary for microbial survival and virulence [7, 8]. Because many microbial lipids possess distinct structures or are entirely absent in mammalian cells, they are highly effective targets for selective antimicrobial agents [8, 17]. For example, polymyxins exert bactericidal activity by binding to Lipid A and disrupting the outer membrane, while polyene antifungals like amphotericin B bind to ergosterol to create lethal pores in fungal membranes [3, 8]. Other therapeutic approaches involve the inhibition of enzymes required for lipid biosynthesis, such as the targeting of mycolic acid production in mycobacteria [14]. Despite their therapeutic utility, drugs targeting microbial lipids often face challenges such as nephrotoxicity, neurotoxicity, and the development of microbial resistance through membrane remodeling and lipid modification [14, 18].

Other names

Microbial membrane lipidsBacterial lipidsFungal lipidsPathogen-specific lipidsMicrobial cell wall lipidsBacterial membrane phospholipids

Drugs targeting microbial lipids typically act through direct binding and disruption of the microbial membrane (leading to pore formation, depolarization, and leakage of cellular contents), sequestration of essential cell wall precursors (e.g., Lipid II), or inhibition of enzymes involved in lipid biosynthetic pathways (e.g., mycolic acid synthesis).